Albert J. ten Tije

9.7k citations

83 papers · 2.1k indexed · h-index 25

Oncology top 2%
- Colorectal Cancer Treatments and Studies 27
- Cancer Treatment and Pharmacology 22
- Cancer Immunotherapy and Biomarkers 16
- CAR-T cell therapy research 14
- Cutaneous Melanoma Detection and Management 12
- HER2/EGFR in Cancer Research 9
Cancer Research top 5%
Biomaterials top 5%
Pulmonary and Respiratory Medicine top 5%
Gastroenterology top 5%
Radiology, Nuclear Medicine and Imaging
- Radiopharmaceutical Chemistry and Applications 11
Molecular Biology
- Melanoma and MAPK Pathways 9

Co-authors: Jaap Verweij Alex Sparreboom Walter J. Loos Geke A.P. Hospers Sharyn D. Baker Hans Gelderblom Michael A. Carducci Wilfried J. Graveland
Cited by: Oncology Cancer Research Biomaterials
Journals: Journal of Clinical Oncology (18 papers)Annals of Oncology (12 papers)European Journal of Cancer (10 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Albert J. ten Tije

81 papers receiving 2.0k citations

Peers

Countries citing papers authored by Albert J. ten Tije

Since Specialization

Citations

This map shows the geographic impact of Albert J. ten Tije's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert J. ten Tije with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert J. ten Tije more than expected).

Fields of papers citing papers by Albert J. ten Tije

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert J. ten Tije. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert J. ten Tije. The network helps show where Albert J. ten Tije may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Albert J. ten Tije, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Albert J. ten Tije Line = papers co-authored together Albert J. ten Tije links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features Nature Communications ·Matheus U Senna Klipp,Marcel Smid,Job van Riet,Lindsay Angus,Mariëtte Labots,Neeltje Steeghs,Mathijs P. Hendriks,Geert A. Cirkel,Johan M. van Rooijen,Albert J. ten Tije,Martijn P. Lolkema,Edwin Cuppen,Stefan Sleijfer,John W.M. Martens,Saskia M. Wilting	2021	45
2	Author Correction: Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features Nature Communications ·Matheus U Senna Klipp,Marcel Smid,Job van Riet,Lindsay Angus,Mariëtte Labots,Neeltje Steeghs,Mathijs P. Hendriks,Geert A. Cirkel,Johan M. van Rooijen,Albert J. ten Tije,Martijn P. Lolkema,Edwin Cuppen,Stefan Sleijfer,John W.M. Martens,Saskia M. Wilting	2021	6
3	Discontinuation of anti‐PD‐1 monotherapy in advanced melanoma—Outcomes of daily clinical practice International Journal of Cancer ·Michiel C.T. van Zeijl,Alfons J.M. van den Eertwegh,Michel W.J.M. Wouters,Liesbeth C. de Wreede,Maureen J.B. Aarts,Franchette W.P.J. van den Berkmortel,Jan‐Willem B. de Groot,Geke A.P. Hospers,Ellen Kapiteijn,Djura Piersma,Rozemarijn S. van Rijn,Karijn P.M. Suijkerbuijk,Albert J. ten Tije,Astrid A.M. van der Veldt,Gerard Vreugdenhil,Jacobus J. M. van der Hoeven,John B.A.G. Haanen	2021	18
4	KEYNOTE-199 cohorts 4 and 5: Pembrolizumab (pembro) plus enzalutamide (enza) for enza-resistant metastatic castration-resistant prostate cancer (mCRPC) European Urology Open Science ·Ray McDermott,Adrián Lozano Lozano,Emmanuel S. Antonarakis,Christopher Hoimes,Zbyšek Podhrázský,Clara Hwang,Deepak Kilari,Albert J. ten Tije,Aurelius Omlin,Ulka N. Vaishampayan,Andrew Elliott,Haiyan Wu,Ryoo Im-Woo,Charles Schloss,Johann S. de Bono	2020	2
5	Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response Cancers ·Monique K. van der Kooij,Guoqi YAN,Maureen J.B. Aarts,Franchette W.P.J. van den Berkmortel,Christian U. Blank,Marye J. Boers‐Sonderen,Miranda P. Dierselhuis,Jan Willem B. de Groot,Geke A.P. Hospers,Djura Piersma,Rozemarijn S. van Rijn,Karijn P.M. Suijkerbuijk,Albert J. ten Tije,Astrid A.M. van der Veldt,Gerard Vreugdenhil,Michel W.J.M. Wouters,John B.A.G. Haanen,Alfonsus Johannes Maria van den Eertwegh,Esther Bastiaannet,Ellen Kapiteijn	2020	32
6	Survival outcomes of patients with advanced mucosal melanoma diagnosed from 2013 to 2017 in the Netherlands – A nationwide population-based study European Journal of Cancer ·Michiel C.T. van Zeijl,Talaat A Hameed,Mariëtte I.E. van Poelgeest,Alfons J.M. van den Eertwegh,Michel W.J.M. Wouters,Liesbeth C. de Wreede,Maureen J.B. Aarts,Franchette W.P.J. van den Berkmortel,Jan Willem B. de Groot,Geke A.P. Hospers,Djura Piersma,Rozemarijn S. van Rijn,Karijn P.M. Suijkerbuijk,Albert J. ten Tije,Astrid A.M. van der Veldt,Gerard Vreugdenhil,Marye J. Boers‐Sonderen,Ellen Kapiteijn,John B.A.G. Haanen	2020	17
7	Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial Radiotherapy and Oncology ·Maxime J.M. van der Valk,Corrie A.M. Marijnen,Boudewijn van Etten,Esmée A. Dijkstra,Denise E. Hilling,Elma Meershoek‐Klein Kranenbarg,Hein Putter,Annet G.H. Roodvoets,Renu R. Bahadoer,Tone Fokstuen,Albert J. ten Tije,Jaume Capdevila,Mathijs P. Hendriks,Ibrahim Edhemović,Andrés Cervantes,Derk Jan A. de Groot,Per J. Nilsson,Bengt Glimelius,Cornelis J.�H. van de Velde,Geke A.P. Hospers	2020	129
8	1120P Post-approval trials versus patient registries: Comparability of advanced melanoma patients with brain metastases Annals of Oncology ·Giuseppe Bizzarri,Nienke O. Sikkes,Michel W.J.M. Wouters,Doranne L. Hilarius,Md Mahmudul,Gülnaz Khadem Saba,Maureen J.B. Aarts,F. Van den Berkmortel,A Tsicotis,Jan Willem B. de Groot,John B.A.G. Haanen,Geke A.P. Hospers,Ellen Kapiteijn,Djura Piersma,Juan Alcaraz Maestre,Karijn P.M. Suijkerbuijk,Albert J. ten Tije,Astrid A.M. van der Veldt,Gerard Vreugdenhil,Maaike van Dartel	2020	1
9	Cumulative dose of bevacizumab associates with albuminuria rather than podocyturia in cancer patients Journal of the American Society of Hypertension ·Stephanie Lankhorst,Hans J. Baelde,Yuting Yang,Albert J. ten Tije,Marc Thelen,A.H. Jan Danser,Anton H. van den Meiracker,Mariëtte H.W. Kappers	2018	2
10	The value of tumour debulking for patients with extensive multi-organ metastatic colorectal cancer European Journal of Cancer ·Elske C. Gootjes,Ivana Daniela Medina,Albert J. ten Tije,Petronella O. Witteveen,Tineke E. Buffart,John Bridgewater,John Primrose,Cornelis Verhoef,Henk M.W. Verheul	2018	8
11	Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study Annals of Oncology ·Ahdha Jangga Buwana,Sjoerd G. Elias,Harm van Tinteren,Miangela M. Laclé,Stefan M. Willems,G.J.A. Offerhaus,Wendy W.J. de Leng,E Strengman,Albert J. ten Tije,G.J. Creemers,杨清华,Felix E. de Jongh,Frans Erdkamp,Bea C. Tanis,Cornelis J.A. Punt,Miriam Koopman	2017	56
12	Practice variation in Sentinel Lymph Node Biopsy for melanoma patients in different geographical regions in the Netherlands Surgical Oncology ·Yuting Yang,Xiangguang Ye,Harald J. Hoekstra,Schelto Kruijff,Albert J. ten Tije,Marieke W.J. Louwman,Esther Bastiaannet,Martijn M. Stuiver	2017	8
13	Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group Annals of Oncology ·Johannes J.M. Kwakman,Lieke H. J. Simkens,Johan M. van Rooijen,Agnès J. van de Wouw,Albert J. ten Tije,G.J. Creemers,Mathijs P. Hendriks,Maartje Los,R J van Alphen,M. Polée,E.W. Muller,Ankie M.T. van der Velden,Theo van Voorthuizen,Miriam Koopman,Linda Mol,Erik van Werkhoven,Cornelis J.A. Punt	2017	47
14	Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer European Journal of Cancer ·P.J. Arango-Arango,B. I. Olson,Anne M. May,Hendrik Koffijberg,Harm van Tinteren,Linda Mol,Albert J. ten Tije,G.J. Creemers,Ankie M.T. van der Velden,Bea C. Tanis,Carin A. Uyl‐de Groot,Cornelis J.A. Punt,Miriam Koopman,Martijn G.H. van Oijen	2017	19
15	Effects of Budesonide on Cabazitaxel Pharmacokinetics and Cabazitaxel-Induced Diarrhea: A Randomized, Open-Label Multicenter Phase II Study Clinical Cancer Research ·Annemieke J.M. Nieuweboer,Anne‐Joy M. de Graan,Paul Hamberg,Sander Bins,Robert J. van Soest,Robbert J. van Alphen,Andries M. Bergman,Aart Beeker,Henk van Halteren,Albert J. ten Tije,Michelle Udayamurthy,Erik K. Fromme,Dana Chiţu,Ronald de Wit,Ron H.J. Mathijssen	2016	12
16	An open-label, multinational, multicentre, phase IIIB umbrella study of subcutaneous trastuzumab with or without chemotherapy or pertuzumab in patients with HER2-positive early or metastatic breast cancer (UmbHER1): Interim safety results from early breast cancer studies Annals of Oncology ·Xavier Pivot,C. J. Poole,Miguel Martín,Joseph Gligorov,C.H. Barrios,Eduard Vrdoljak,Luca Gianni,Albert J. ten Tije,D. A. Weiner,Matt Truman,Guenther G. Steger	2016	1
17	Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients Investigational New Drugs ·Jara M. Baas,Janice O. Bennett,Albert J. ten Tije,Frans Erdkamp,Tom van Wezel,Hans Morreau,Hans Gelderblom,Henk‐Jan Guchelaar	2015	30
18	Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro) European Journal of Cancer ·Hielke J. Meulenbeld,Erik van Werkhoven,J.L. Coenen,G.J. Creemers,O. J. L. Loosveld,P.C. de Jong,Albert J. ten Tije,Sophie D. Fosså,M. Polée,Winald R. Gerritsen,Otilia Dalesio,Ronald de Wit	2012	31
19	Limited cerebrospinal fluid penetration of docetaxel Anti-Cancer Drugs ·Albert J. ten Tije,Walter J. Loos,Ming Zhao,Sharyn D. Baker,Roelien H. Enting,H. van der Meulen,Jaap Verweij,Alex Sparreboom	2004	16
20	Preclinical evaluation of alternative pharmaceutical delivery vehicles for paclitaxel Anti-Cancer Drugs ·Walter J. Loos,János Szebeni,Albert J. ten Tije,Jaap Verweij,Rodrigo Fernández,Shahrieel Aras,Kees Nooter,G. Stoter,Alex Sparreboom	2002	21

About Albert J. ten Tije

Albert J. ten Tije is a scholar working on Oncology, Cancer Research, Hepatology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 83 papers that have together received 2.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (27 papers), Cancer Treatment and Pharmacology (22 papers), Cancer Immunotherapy and Biomarkers (16 papers), CAR-T cell therapy research (14 papers), Cutaneous Melanoma Detection and Management (12 papers), Radiopharmaceutical Chemistry and Applications (11 papers), Melanoma and MAPK Pathways (9 papers) and HER2/EGFR in Cancer Research (9 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (313 citations), Biomaterials (217 citations), Pulmonary and Respiratory Medicine (506 citations) and Gastroenterology (73 citations). Albert J. ten Tije has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Jaap Verweij, Alex Sparreboom, Walter J. Loos, Geke A.P. Hospers, Sharyn D. Baker, Hans Gelderblom, Michael A. Carducci, Wilfried J. Graveland, Fitzroy W. Dawkins and Mathijs P. Hendriks. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancers and Acta Oncologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact